Portfolio company
CynosBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops regenerative medicine products, including autologous cell therapies for ophthalmology and orthopaedics, serving healthcare professionals and patients with severe unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
StemSight
This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.
Aceso Stem Biostrategies Inc
This company develops regenerative cell therapies for musculoskeletal disorders to treat patients with rotator cuff tears and osteoarthritis.
Rejuveron Life Sciences AG
This biotechnology company develops regenerative therapies and medicines for patients with age-related diseases and vision loss.
Holostem Srl
This biotechnology company develops and manufactures advanced therapy medicinal products based on epithelial stem cell cultures for patients with rare ocular and skin diseases.
Character Biosciences
This company develops precision medicines and companion diagnostics for degenerative eye diseases, serving patients and pharmaceutical partners.
Treefrog Therapeutics
This company develops a stem cell production platform to provide regenerative medicine therapies for pharmaceutical firms and patients with neurodegenerative diseases.
Eyestem
The company develops cell replacement therapies to treat incurable blindness and retinal diseases for patients globally.
Scinus Group
This company develops automated, closed bioreactor systems for large-scale cell expansion, serving the cell therapy and regenerative medicine industries.
